Insider Transactions in Q1 2026 at Eton Pharmaceuticals, Inc. (ETON)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 14
2026
|
James R. Gruber Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,293
-1.06%
|
$34,395
$15.47 P/Share
|
|
Jan 14
2026
|
David Krempa Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,942
-0.31%
|
$29,130
$15.62 P/Share
|
|
Jan 01
2026
|
Sean Brynjelsen President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,015
-0.17%
|
$75,225
$15.39 P/Share
|